Author

F. Ianevski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

C. A. Heckman· 1 shared E. Gholizadeh· 1 shared J. J. Miettinen· 1 shared J. Saarela· 1 shared M. Jafari· 1 shared M. Manninen· 1 shared M. Mirzaie· 1 shared S. Miettinen· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. A. Heckman

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Designing patient-oriented combination therapies for acute myeloid leukemia based on efficacy/toxicity integration and bipartite network modeling

M. Mirzaie, E. Gholizadeh, J. J. Miettinen, T. Ruokoranta, F. Ianevski, J. Saarela, M. Manninen, S. Miettinen, C. A. Heckman, M. Jafari

This paper identifies effective and low-toxicity drug combinations for AML using a bipartite network model and patient-derived data, finding ruxolitinib-ulixertinib and sapanisertib-LY3009120 as the most synergistic.

bioRxiv · May 25, 2023Cancer Biology